In light of the foregoing data demonstrating that CD8+PD-1+ T cells are tumor-reactive, and their expansion correlated with the outcomes of patients treated with ACT and considering the role of the TCR repertoire in the antitumor response, we sought to assess the relationship between the CD8+PD-1+ T-cell frequency and the TCR repertoire. Here, PDCD1 is linked to neoplasm.